{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:38:09Z","timestamp":1759412289737},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1097\/inf.0000000000000228","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T09:34:23Z","timestamp":1390556063000},"page":"284-290","source":"Crossref","is-referenced-by-count":13,"title":["A Consensus Statement"],"prefix":"10.1097","volume":"33","author":[{"given":"Ricardo Walter","family":"R\u00fcttimann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes Macias","family":"Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Saez-Llorens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Aurelio Palazzi","family":"Safadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Elena","family":"Santolaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-17-20210202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/016164110X12644252260754","article-title":"Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention.","volume":"32","author":"Safadi","year":"2010","journal-title":"Neurol Res"},{"key":"R3-17-20210202","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2011.02.058","article-title":"The global meningococcal initiative: recommendations for reducing the global burden of meningococcal disease.","volume":"29","author":"Harrison","year":"2011","journal-title":"Vaccine"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"e44102","DOI":"10.1371\/journal.pone.0044102","article-title":"Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010.","volume":"7","author":"Ibarz-Pavon","year":"2012","journal-title":"PLoS One"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1128\/JCM.42.7.2919-2925.2004","article-title":"Prospective study of a real-time PCR that is highly sensitive, specific, and clinically useful for diagnosis of meningococcal disease in children.","volume":"42","author":"Bryant","year":"2004","journal-title":"J Clin Microbiol"},{"key":"R7-17-20210202","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1128\/JCM.06087-11","article-title":"Clinical validation of multiplex real-time PCR assays for detection of bacterial meningitis pathogens.","volume":"50","author":"Wang","year":"2012","journal-title":"J Clin Microbiol"},{"key":"R8-17-20210202","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1128\/JCM.39.4.1553-1558.2001","article-title":"Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR.","volume":"39","author":"Corless","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"suppl 2","key":"R9-17-20210202","doi-asserted-by":"crossref","first-page":"B78","DOI":"10.1016\/j.vaccine.2011.12.099","article-title":"Future challenges in the elimination of bacterial meningitis.","volume":"30","author":"Bottomley","year":"2012","journal-title":"Vaccine"},{"key":"R10-17-20210202","first-page":"124","article-title":"Epidemiology and diagnosis of meningitis: results of a five-year prospective, population-based study.","volume":"4","author":"Jolly","year":"2001","journal-title":"Commun Dis Public Health"},{"key":"R11-17-20210202","doi-asserted-by":"crossref","first-page":"e20675","DOI":"10.1371\/journal.pone.0020675","article-title":"Sao Paulo RT-PCR Surveillance Project Team. Incorporation of real-time PCR into routine public health surveillance of culture negative bacterial meningitis in Sao Paulo, Brazil.","volume":"6","author":"Sacchi","year":"2011","journal-title":"PLoS One"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3201\/eid1703.101254","article-title":"Surveillance for invasive meningococcal disease in children, US-Mexico border, 2005-2008.","volume":"17","author":"Chacon-Cruz","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"R14-17-20210202","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","article-title":"Social contacts and mixing patterns relevant to the spread of infectious diseases.","volume":"5","author":"Mossong","year":"2008","journal-title":"PLoS Med"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1586\/14737159.6.1.79","article-title":"Molecular methods for the detection and characterization of Neisseria meningitidis.","volume":"6","author":"Diggle","year":"2006","journal-title":"Expert Rev Mol Diagn"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1128\/CMR.19.1.142-164.2006","article-title":"Prospects for vaccine prevention of meningococcal infection.","volume":"19","author":"Harrison","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"R18-17-20210202","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jinf.2008.12.005","article-title":"Sampling methods to detect carriage of Neisseria meningitidis; literature review.","volume":"58","author":"Roberts","year":"2009","journal-title":"J Infect"},{"key":"R19-17-20210202","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis.","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R20-17-20210202","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1590\/S0036-36342009000200006","article-title":"Prevalence of Neisseria meningitidis carriers in children under five years of age and teenagers in certain populations of Mexico City.","volume":"51","author":"Espinosa de los Monteros","year":"2009","journal-title":"Salud Publica de Mex"},{"issue":"suppl 2","key":"R21-17-20210202","doi-asserted-by":"crossref","first-page":"B71","DOI":"10.1016\/j.vaccine.2009.04.070","article-title":"Biology and pathogenesis of the evolutionarily successful, obligate human bacterium Neisseria meningitidis.","volume":"27","author":"Stephens","year":"2009","journal-title":"Vaccine"},{"key":"R22-17-20210202","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"W135 Working Group. Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"R23-17-20210202","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1128\/JCM.02390-08","article-title":"W135 invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina.","volume":"47","author":"Efron","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R25-17-20210202","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/erv.09.48","article-title":"Meningococcal vaccines and herd immunity: lessons learned from serogroup C conjugate vaccination programs.","volume":"8","author":"Trotter","year":"2009","journal-title":"Expert Rev Vaccines"},{"key":"R27-17-20210202","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1016\/j.vaccine.2010.09.092","article-title":"Comparison of the safety and immunogenicity of an investigational and a licensed quadrivalent meningococcal conjugate vaccine in children 2-10 years of age.","volume":"28","author":"Halperin","year":"2010","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R28-17-20210202","doi-asserted-by":"crossref","first-page":"B37","DOI":"10.1016\/j.vaccine.2011.12.074","article-title":"Meningococcal disease from the public health policy perspective.","volume":"30","author":"Black","year":"2012","journal-title":"Vaccine"},{"key":"R29-17-20210202","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/BF00415493","article-title":"Appearance of new strains associated with group B meningococcal disease and their use for rapid vaccine development.","volume":"53","author":"Frasch","year":"1987","journal-title":"Antonie Van Leeuwenhoek"},{"issue":"suppl 2","key":"R30-17-20210202","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1086\/648966","article-title":"Review of meningococcal group B vaccines.","volume":"50","author":"Granoff","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"suppl 2","key":"R31-17-20210202","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease.","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"R32-17-20210202","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(11)61713-3","article-title":"V72P10 Meningococcal B Adolescent Vaccine Study group. Immunogenicity and tolerability of a multicomponent meningococcal serogroup B (4CMenB) vaccine in healthy adolescents in Chile: a phase 2b3 randomised, observer-blind, placebo-controlled study.","volume":"379","author":"Santolaya","year":"2012","journal-title":"Lancet"},{"key":"R33-17-20210202","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(12)70087-7","article-title":"2001 Study Investigators. Safety, immunogenicity, and tolerability of meningococcal serogroup B bivalent recombinant lipoprotein 2086 vaccine in healthy adolescents: a randomised, single-blind, placebo-controlled, phase 2 trial.","volume":"12","author":"Richmond","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"R34-17-20210202","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"R35-17-20210202","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S0264-410X(02)00591-1","article-title":"Serum bactericidal activity correlates with the vaccine efficacy of outer membrane vesicle vaccines against Neisseria meningitidis serogroup B disease.","volume":"21","author":"Holst","year":"2003","journal-title":"Vaccine"},{"key":"R36-17-20210202","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1006\/biol.2000.0253","article-title":"Standardisation and validation of serological assays for the evaluation of immune responses to Neisseria meningitidis serogroup A and C vaccines.","volume":"28","author":"Jodar","year":"2000","journal-title":"Biologicals"},{"key":"R37-17-20210202","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"R38-17-20210202","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1086\/344324","article-title":"Antibody persistence and immunological memory at age 4 years after meningococcal group C conjugate vaccination in children in the United kingdom.","volume":"186","author":"Borrow","year":"2002","journal-title":"J Infect Dis"},{"key":"R39-17-20210202","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/JCM.32.6.1475-1482.1994","article-title":"Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay.","volume":"32","author":"Gheesling","year":"1994","journal-title":"J Clin Microbiol"},{"key":"R40-17-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","article-title":"Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction.","volume":"364","author":"Trotter","year":"2004","journal-title":"Lancet"},{"key":"R42-17-20210202","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity.","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"key":"R45-17-20210202","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37757\/MR2007V9.N1.6","article-title":"Cuban meningococcal BC vaccine: Experiences contributions from 20 years of application.","volume":"9","author":"Padron","year":"2007","journal-title":"MEDICC Rev"},{"key":"R46-17-20210202","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/0140-6736(92)93086-3","article-title":"Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil.","volume":"340","author":"de Moraes","year":"1992","journal-title":"Lancet"},{"key":"R47-17-20210202","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/aje\/kwm147","article-title":"A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.","volume":"166","author":"Kelly","year":"2007","journal-title":"Am J Epidemiol"},{"key":"R48-17-20210202","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1016\/j.vaccine.2006.03.091","article-title":"Neisseria meningitidis group B correlates of protection and assay standardization-international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005.","volume":"24","author":"Borrow","year":"2006","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R49-17-20210202","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/j.vaccine.2011.12.060","article-title":"History of meningococcal vaccines and their serological correlates of protection.","volume":"30","author":"Vipond","year":"2012","journal-title":"Vaccine"},{"issue":"suppl 2","key":"R50-17-20210202","doi-asserted-by":"crossref","first-page":"B18","DOI":"10.1016\/j.vaccine.2012.01.062","article-title":"Meningococcal vaccine development-from glycoconjugates against MenACWY to proteins against MenB-potential for broad protection against meningococcal disease.","volume":"30","author":"Dull","year":"2012","journal-title":"Vaccine"},{"key":"R52-17-20210202","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1586\/erv.11.159","article-title":"Epidemiology and prevention of meningococcal disease: a critical appraisal of vaccine policies.","volume":"10","author":"Safadi","year":"2011","journal-title":"Expert Rev Vaccines"},{"key":"R53-17-20210202","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bmb\/62.1.201","article-title":"Vaccine programmes and policies.","volume":"62","author":"Salisbury","year":"2002","journal-title":"Br Med Bull"},{"key":"R54-17-20210202","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jval.2011.05.045","article-title":"Cost-effectiveness analysis of a universal infant immunization program with meningococcal C conjugate vaccine in Brazil.","volume":"14","author":"de Soarez","year":"2011","journal-title":"Value Health"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000000228","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:45:28Z","timestamp":1688949928000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006454-201403000-00017"}},"subtitle":["Meningococcal Disease Among Infants, Children and Adolescents in Latin America"],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000000228","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}